Cargando…
CD5L is a pleiotropic player in liver fibrosis controlling damage, fibrosis and immune cell content
BACKGROUND: Chronic hepatic inflammation leads to liver fibrosis, which may progress to cirrhosis, a condition with high morbidity. Our aim was to assess the as yet unknown role of innate immunity protein CD5L in liver fibrosis. METHODS: CD5L was measured by ELISA in plasma samples from cirrhotic (n...
Autores principales: | Bárcena, Cristina, Aran, Gemma, Perea, Luís, Sanjurjo, Lucía, Téllez, Érica, Oncins, Anna, Masnou, Helena, Serra, Isabel, García-Gallo, Mónica, Kremer, Leonor, Sala, Margarita, Armengol, Carolina, Sancho-Bru, Pau, Sarrias, Maria-Rosa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558273/ https://www.ncbi.nlm.nih.gov/pubmed/31076347 http://dx.doi.org/10.1016/j.ebiom.2019.04.052 |
Ejemplares similares
-
CD5L Promotes M2 Macrophage Polarization through Autophagy-Mediated Upregulation of ID3
por: Sanjurjo, Lucía, et al.
Publicado: (2018) -
The human CD5L/AIM-CD36 axis: A novel autophagy inducer in macrophages that modulates inflammatory responses
por: Sanjurjo, Lucía, et al.
Publicado: (2015) -
Macrophage CD5L is a target for cancer immunotherapy
por: Sanchez-Moral, Lidia, et al.
Publicado: (2023) -
The Endothelium as a Driver of Liver Fibrosis and Regeneration
por: Lafoz, Erica, et al.
Publicado: (2020) -
Pleiotropic effects of CD5L in hepatic inflammation and fibrosis
por: Zhou, Tianhao, et al.
Publicado: (2019)